Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma
NCT00541424 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-12-06
Summary
The goal of this clinical research study is to learn if positron emission tomography (PET)/computed tomography (CT) scanning can be used to detect mantle cell lymphoma in the colon. Researchers want to learn if PET/CT scanning can produce good-quality images and/or find the exact locations of lymphoma in the body.
Primary Objective is to determine if combined CT colonography and full body PET scan is technically feasible and can produce diagnostic scans as well as accurate anatomic coordination for detection of mantle cell lymphoma involvement of the colon.
Conditions
Interventions
- PROCEDURE
-
PET/CT Scanning
Full-body PET/CT procedure will be performed. Gas will be pumped into the colon before the scan so the colon will be opened up (inflated) and the study doctor will be able to more easily look for any lesions. This procedure is called gas insufflation.
Sponsors & Collaborators
-
M.D. Anderson Cancer Center
lead OTHER
Principal Investigators
-
Revathy B. Iyer, MD · M.D. Anderson Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2008-11-30
- Completion
- 2008-11-30
More Related Trials
-
Whole-Body MRI and Conventional Imaging in Detecting Distant Metastases in Young Patients With Solid Tumors or Lymphoma
NCT00072488 ·Status: UNKNOWN ·Phase: NA
-
The Role of 18F-FDG-PET for Staging and Prognostication
NCT04600804 ·Status: COMPLETED
-
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT02042924 ·Status: TERMINATED ·Phase: NA
-
Positron Emission Tomography(PET) in Lymphoma Assessment
NCT00887718 ·Status: COMPLETED ·Phase: NA
-
PET-CT in the Management of Patients With Stage III or IV Metastatic Melanoma
NCT00828126 ·Status: COMPLETED
-
Diagnostic Imaging of Myeloma Bone Lesions
NCT03147326 ·Status: COMPLETED ·Phase: NA
-
PET/CT Imaging of Malignant Brain Tumors With 124I-NM404
NCT01516905 ·Status: COMPLETED
-
Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases
NCT05408871 ·Status: TERMINATED ·Phase: PHASE1
-
The Value of Pelvic Magnetic Resonance Imaging in Detecting Bone Marrow Infiltration of Lymphoma
NCT03973164 ·Status: COMPLETED
-
18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
NCT05096234 ·Status: TERMINATED ·Phase: PHASE1
-
PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer
NCT03146117 ·Status: TERMINATED
-
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
NCT04478318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
NCT04493411 ·Status: TERMINATED ·Phase: NA
-
Detection of Cervical Lymph Node Metastases With a High-Resolution Positron Emission Tomography (PET) Imaging System
NCT01030497 ·Status: COMPLETED
-
The Performance of Multi-tracer Multimodality PET in Lymphoma
NCT05004961 ·Status: UNKNOWN
-
MRI and PET to Assess Pembrolizumab Response
NCT02591654 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)
NCT01004718 ·Status: COMPLETED ·Phase: NA
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Helical CT, PET/CT, MRI, and CBCT Alone or in Combination in Predicting Jaw Invasion in Patients With Oral Cancer
NCT03053960 ·Status: TERMINATED
-
Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents
NCT02488369 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
NCT01557881 ·Status: TERMINATED ·Phase: NA
-
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
NCT00775268 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Combining Intratumoral Metabolic Heterogeneity and Dissemination Feature (Dmax) on 18F-FDG PET/CT Improves Prognosis Prediction in DLBCL
NCT05113576 ·Status: COMPLETED
-
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
NCT01540513 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT Imaging as Early Predictor of DP
NCT02476734 ·Status: COMPLETED